Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.
Relating to the provision of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and the use of public money or public assistance to provide those procedures or treatments.